Highlights
NASDAQ: TSRO       Tesaro Inc
Last Price Today's Change   Day's Range   Trading Volume
109.05   -3.94 (3.49%)  106.64 - 115.80  2,407,867

Overview

 
Avg Volume (4 weeks):988,031
4 Weeks Range:106.64 - 137.25
4 Weeks Price Volatility (%):
7.87%
52 Weeks Range:83.26 - 192.94
52 Weeks Price Volatility (%):
23.51%
Average Price Target: 70.00
Price Target Upside/Downside: -39.05

Headlines



No recent Headlines for this stock.


Business Background

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

  Be the first to like this.
 


 

1659  5610  516  645 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 13.649+1.899 
 DCTH 0.168+0.027 
 SPY 243.14-3.80 
 UVXY 41.10+10.23 
 BAC 23.64-0.55 
 XLF 24.61-0.43 
 QQQ 141.33-2.95 
 EEM 43.29-0.57 
 BABA 163.92+4.42 
 CSCO 31.04-1.30 
Partners & Brokers